Allergan Triumphs In Suits Over Generic Combigan

Law360, New York (August 22, 2011, 8:54 PM EDT) -- A Texas federal judge on Monday ruled for Allergan Inc. in four consolidated patent suits accusing generic-drug makers of infringing patents for glaucoma medication Combigan.

After a bench trial, U.S. District Judge T. John Ward ruled that Sandoz Inc., Alcon Laboratories Inc. and its affiliates Apotex Inc. and Watson Laboratories Inc. infringed four Allergan patents in their efforts to market a generic version of Combigan.

The judge enjoined the generics companies from making, using, offering to sell or selling their own versions of brimonidine tartrate/timolol maleate...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.